Leerink Swann Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Leerink Swann. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Leerink Swann.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
4/18/2018Leerink SwannReiteratesJohnson & Johnson (JNJ)Outperform$175.00 -> $160.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/18/2018Leerink SwannReiteratesIntuitive Surgical (ISRG)Outperform$475.00 -> $510.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Leerink SwannReiteratesTrillium Therapeutics (TR)Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
4/13/2018Leerink SwannInitiatesTrillium Therapeutics (TRIL)Mkt Perform -> Market Perform $7.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/12/2018Leerink SwannUpgradesMylan (MYL)Market Perform -> Outperform $44.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/11/2018Leerink SwannRaises TargetCymaBay Therapeutics (CBAY)Outperform$16.00 -> $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/10/2018Leerink SwannSet Price TargetCVS Health (CVS)Buy $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018Leerink SwannReiteratesMacroGenics (MGNX)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
4/9/2018Leerink SwannInitiatesArcus Biosciences (RCUS)Outperform -> Outperform $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/6/2018Leerink SwannReiteratesCalithera Biosciences (CALA)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018Leerink SwannUpgradesArQule (ARQL)Market Perform -> OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
4/4/2018Leerink SwannInitiatesAdamas Pharmaceuticals (ADMS)Outperform -> Outperform $31.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2018Leerink SwannInitiatesVericel (VCEL)Outperform -> Outperform $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/3/2018Leerink SwannSet Price TargetIntra-Cellular Therapies (ITCI)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2018Leerink SwannUpgradesHenry Schein (HSIC)Market Perform -> Outperform $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannReiteratesMersana Therapeutics (MRSN)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Leerink SwannReiteratesKaryopharm Therapeutics (KPTI)Outperform -> Outperform $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Leerink SwannReiteratesAscendis Pharma (ASND)Mkt Perform -> Market Perform$37.00 -> $64.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Leerink SwannLowers TargetSolid Biosciences (SLDB)Outperform -> Hold$36.00 -> $14.00MediumView Rating Details  Share on Twitter  Share on StockTwits
4/2/2018Leerink SwannRaises TargetInflarx (IFRX)Outperform$31.00 -> $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018Leerink SwannLowers TargetNeovasc (NVCN)Outperform -> Outperform$5.00 -> $2.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/29/2018Leerink SwannInitiatesRadius Health (RDUS)Outperform -> Outperform $53.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannRaises TargetMolina Healthcare (MOH)Outperform$100.00 -> $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannLowers TargetAclaris Therapeutics (ACRS)Outperform -> Outperform$54.00 -> $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannSet Price TargetEXACT Sciences (EXAS)Buy $67.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannSet Price TargetCelgene (CELG)Buy $123.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannReiteratesXencor (XNCR)Outperform -> Outperform $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/28/2018Leerink SwannReiteratesGlobus Medical (GMED)Outperform -> Outperform$56.00 -> $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/26/2018Leerink SwannReiteratesImmunoGen (IMGN)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
3/26/2018Leerink SwannReiteratesAllergan (AGN)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/27/2018Leerink SwannUpgradesARMO BioSciences (ARMO)Market Perform -> Outperform $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018Leerink SwannReiteratesZai Lab (ZLAB)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/22/2018Leerink SwannReiteratesDermira (DERM)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Leerink SwannReiteratesAdaptimmune Therapeutics (ADAP)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018Leerink SwannReiteratesArdelyx (ARDX)Outperform -> Outperform $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/16/2018Leerink SwannInitiatesAdaptimmune Therapeutics (ADAP)Buy $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/14/2018Leerink SwannReiteratesIntellia Therapeutics (NTLA)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2018Leerink SwannUpgradesMagellan Health (MGLN)Market Perform -> OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
3/14/2018Leerink SwannRaises TargetEpizyme (EPZM)Outperform -> Outperform$22.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Leerink SwannLowers TargetWAVE Life Sciences (WVE)Outperform -> Outperform$64.00 -> $62.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Leerink SwannLowers TargetAclaris Therapeutics (ACRS)Outperform -> Outperform$56.00 -> $54.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Leerink SwannReiteratesSarepta Therapeutics (SRPT)Outperform -> Positive$79.00 -> $92.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/13/2018Leerink SwannDowngradesVocera Communications (VCRA)Outperform -> Market Perform $29.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/12/2018Leerink SwannUpgradesMerck & Co. (MRK)Market Perform -> OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Leerink SwannReiteratesCelldex Therapeutics (CLDX)Market Perform -> Market Perform$4.00 -> $3.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018Leerink SwannDowngradesAmerican Renal Associates (ARA)Outperform -> Market Perform$17.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesZogenix (ZGNX)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesWAVE Life Sciences (WVE)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesParatek Pharmaceuticals (PRTK)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesIntra-Cellular Therapies (ITCI)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesAlder BioPharmaceuticals (ALDR)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/4/2018Leerink SwannReiteratesAchaogen (AKAO)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
3/5/2018Leerink SwannDowngradesLifePoint Health (LPNT)Outperform -> Market Perform$46.30 -> $58.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/28/2018Leerink SwannReiteratesTesaro (TSRO)Outperform$123.00 -> $105.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/28/2018Leerink SwannReiteratesFibroGen (FGEN)Outperform$80.00 -> $88.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018Leerink SwannRaises TargetObsEva (OBSV)Outperform -> Outperform$17.00 -> $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018Leerink SwannSet Price TargetDiplomat Pharmacy (DPLO)Outperform -> Buy$32.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018Leerink SwannRaises TargetNuVasive (NUVA)Market Perform -> Market Perform$51.00 -> $52.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Leerink SwannRaises TargetZogenix (ZGNX)Outperform -> Outperform$50.00 -> $54.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Leerink SwannLowers TargetTeleflex (TFX)Outperform -> Outperform$321.00 -> $300.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Leerink SwannLowers TargetBioMarin Pharmaceutical (BMRN)Outperform -> Outperform$142.00 -> $132.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018Leerink SwannSet Price TargetEXACT Sciences (EXAS)Buy $67.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/22/2018Leerink SwannReiteratesGilead Sciences (GILD)Mkt Perform -> Market Perform$83.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/20/2018Leerink SwannReiteratesARMO BioSciences (ARMO)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
2/21/2018Leerink SwannRaises TargetWAVE Life Sciences (WVE)Outperform -> Outperform$53.00 -> $64.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/21/2018Leerink SwannSet Price TargetHenry Schein (HSIC)Market Perform -> Hold$77.00 -> $75.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/20/2018Leerink SwannRaises TargetNeurocrine Biosciences (NBIX)Outperform$90.00 -> $96.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/20/2018Leerink SwannInitiatesSolid Biosciences (SLDB)Outperform -> Outperform $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/20/2018Leerink SwannInitiatesresTORbio (TORC)Outperform -> Outperform $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/14/2018Leerink SwannLowers TargetMerck & Co. (MRK)Mkt Perform -> Market Perform$67.00 -> $66.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/13/2018Leerink SwannReiteratesHenry Schein (HSIC)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
2/13/2018Leerink SwannReiteratesCentene (CNC)Market Perform -> Market Perform$100.00 -> $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannLowers TargetVocera Communications (VCRA)Outperform -> Outperform$34.00 -> $31.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannLowers TargetTeva Pharmaceutical Industries (TEVA)Underweight -> Underperform$17.00 -> $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannLowers TargetRegeneron (REGN)Outperform -> Outperform$568.00 -> $502.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannSet Price TargetCVS Health (CVS)Outperform -> Buy$90.00 -> $85.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannRaises TargetBruker (BRKR)Market Perform -> Market Perform$32.00 -> $34.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannLowers TargetAlexion Pharmaceuticals (ALXN)Outperform -> Outperform$166.00 -> $153.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/9/2018Leerink SwannSet Price TargetEXACT Sciences (EXAS)Buy $67.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Leerink SwannRaises TargetTheravance Biopharma (TBPH)Outperform$45.00 -> $48.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Leerink SwannRaises TargetAmicus Therapeutics (FOLD)Outperform -> Outperform$20.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Leerink SwannLowers TargetCardiovascular Systems (CSII)Outperform -> Outperform$31.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018Leerink SwannRaises TargetHumana (HUM)Outperform -> Outperform$280.00 -> $300.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2018Leerink SwannRaises TargetMyriad Genetics (MYGN)Market Perform -> Market Perform$33.00 -> $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/7/2018Leerink SwannLowers TargetGilead Sciences (GILD)Market Perform -> Market Perform$86.00 -> $83.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/7/2018Leerink SwannRaises TargetArray Biopharma (ARRY)Outperform -> Outperform$19.00 -> $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/7/2018Leerink SwannRaises TargetAllergan (AGN)Outperform -> Outperform$237.00 -> $242.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/6/2018Leerink SwannLowers TargetMerck & Co. (MRK)Market Perform -> Market Perform$69.00 -> $67.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2018Leerink SwannRaises TargetGW Pharmaceuticals (GWPH)Outperform -> Outperform$153.00 -> $157.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/6/2018Leerink SwannRaises TargetAstraZeneca (AZN)Market Perform -> Market Perform$36.00 -> $38.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/6/2018Leerink SwannRaises TargetBristol-Myers Squibb (BMY)Outperform -> Positive$71.00 -> $76.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018Leerink SwannReiteratesAmgen (AMGN)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018Leerink SwannReiteratesAMAG Pharmaceuticals (AMAG)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018Leerink SwannRaises TargetAbiomed (ABMD)Outperform $300.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/1/2018Leerink SwannReiteratesThermo Fisher Scientific (TMO)Outperform$200.00 -> $239.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/1/2018Leerink SwannReiteratesVertex Pharmaceuticals (VRTX)Outperform$175.00 -> $190.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/1/2018Leerink SwannDowngradesNuVasive (NUVA)Outperform -> Market PerformMediumView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetZimmer Biomet (ZBH)Outperform -> Outperform$142.00 -> $146.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetStryker (SYK)Outperform -> Outperform$177.00 -> $184.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetPfizer (PFE)Market Perform -> Market Perform$35.00 -> $38.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetIllumina (ILMN)Outperform -> Outperform$250.00 -> $276.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetHospital Co. of America (HCA)Outperform -> Outperform$105.00 -> $120.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/31/2018Leerink SwannRaises TargetAlign Technology (ALGN)Outperform -> Outperform$300.00 -> $305.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/30/2018Leerink SwannReiteratesTeleflex (TFX)Buy$307.00 -> $321.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/29/2018Leerink SwannDowngradesAbbVie (ABBV)Outperform -> Market Perform $127.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/26/2018Leerink SwannRaises TargetTeva Pharmaceutical Industries (TEVA)Underperform$15.00 -> $17.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/25/2018Leerink SwannReiteratesAbbott Laboratories (ABT)Market Perform$60.00 -> $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/25/2018Leerink SwannRaises TargetAlnylam Pharmaceuticals (ALNY)Market Perform -> Market Perform$132.00 -> $135.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/25/2018Leerink SwannDowngradesbluebird bio (BLUE)Outperform -> Market Perform$162.00 -> $194.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/23/2018Leerink SwannReiteratesGW Pharmaceuticals (GWPH)Buy $153.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/23/2018Leerink SwannDowngradesJuno Therapeutics (JUNO)Outperform -> Market Perform$56.00 -> $87.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/22/2018Leerink SwannUpgradesArray Biopharma (ARRY)Market Perform -> OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
1/19/2018Leerink SwannReiteratesAbbott Laboratories (ABT)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
1/19/2018Leerink SwannRaises TargetAbiomed (ABMD)Outperform -> Outperform$200.00 -> $265.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/19/2018Leerink SwannReiteratesSarepta Therapeutics (SRPT)Outperform $77.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/18/2018Leerink SwannReiteratesAstraZeneca (AZN)Mkt Perform -> Market Perform$33.00 -> $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/18/2018Leerink SwannReiteratesIntuitive Surgical (ISRG)Outperform -> Outperform$390.00 -> $475.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/17/2018Leerink SwannRaises TargetDermira (DERM)Outperform$42.00 -> $48.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/17/2018Leerink SwannReiteratesArena Pharmaceuticals (ARNA)Outperform -> Positive$53.00 -> $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2018Leerink SwannLowers TargetInvitae (NVTA)Outperform -> Outperform$12.00 -> $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/9/2018Leerink SwannRaises TargetMolina Healthcare (MOH)Outperform$100.00 -> $105.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/8/2018Leerink SwannRaises TargetCVS Health (CVS)Outperform -> Outperform$82.00 -> $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/5/2018Leerink SwannInitiatesRegulus Therapeutics (RGLS)Outperform -> Outperform $2.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesMallinckrodt (MNK)Mkt Perform -> Market Perform $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesMylan (MYL)Mkt Perform -> Market Perform $44.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesPacira Pharmaceuticals (PCRX)Mkt Perform -> Market Perform $46.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesPerrigo (PRGO)Mkt Perform -> Market Perform $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesEndo International (ENDP)Outperform -> Outperform $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesHeron Therapeutics (HRTX)Outperform -> Outperform $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesImpax Laboratories (IPXL)Outperform -> Outperform $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesJazz Pharmaceuticals (JAZZ)Outperform -> Outperform $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesTeva Pharmaceutical Industries (TEVA)Underperform -> Underperform $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannSet Price TargetAmerisourceBergen (ABC)Buy$90.00 -> $105.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannReiteratesSucampo Pharmaceuticals (SCMP)Outperform -> Market Perform $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/2/2018Leerink SwannInitiatesQuanterix (QTRX)Outperform -> Outperform $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/22/2017Leerink SwannReiteratesCelgene (CELG)Buy $120.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/20/2017Leerink SwannReiteratesTenet Healthcare (THC)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/13/2017Leerink SwannReiteratesCelgene (CELG)Buy $120.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/12/2017Leerink SwannRaises TargetProteostasis Therapeutics (PTI)$6.00 -> $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/12/2017Leerink SwannInitiatesScpharmaceuticals (SCPH)Outperform -> Outperform $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/12/2017Leerink SwannDowngradesSpark Therapeutics (ONCE)Outperform -> Market Perform $49.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2017Leerink SwannReiteratesAchillion Pharmaceuticals (ACHN)Buy $5.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/11/2017Leerink SwannUpgradesDiplomat Pharmacy (DPLO)Market Perform -> Outperform $23.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/7/2017Leerink SwannRaises TargetSAGE Therapeutics (SAGE)$123.00 -> $246.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/6/2017Leerink SwannReiteratesAlexion Pharmaceuticals (ALXN)Buy $169.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/5/2017Leerink SwannSet Price TargetAbbVie (ABBV)Buy $106.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/5/2017Leerink SwannReiteratesBio-Techne (TECH)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
12/4/2017Leerink SwannReiteratesThermo Fisher Scientific (TMO)Outperform$216.00 -> $200.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/4/2017Leerink SwannSet Price TargetCVS Health (CVS)Buy $85.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/4/2017Leerink SwannInitiatesInflarx (IFRX)Outperform $31.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/1/2017Leerink SwannReiteratesUnitedHealth Group (UNH)OutperformLowView Rating Details  Share on Twitter  Share on StockTwits
11/28/2017Leerink SwannReiteratesCymaBay Therapeutics (CBAY)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/28/2017Leerink SwannReiteratesIntercept Pharmaceuticals (ICPT)Hold $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/27/2017Leerink SwannReiteratesAllergan (AGN)Outperform -> Outperform $237.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/25/2017Leerink SwannReiteratesCerner (CERN)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
11/21/2017Leerink SwannRaises TargetAxoGen (AXGN)Outperform -> Outperform$26.00 -> $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/21/2017Leerink SwannReiteratesAmerican Renal Associates (ARA)Outperform$22.00 -> $17.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/18/2017Leerink SwannSet Price TargetEvolent Health (EVH)Buy $25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/15/2017Leerink SwannLowers TargetAcorda Therapeutics (ACOR)Market Perform $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/15/2017Leerink SwannReiteratesAudentes Therapeutics (BOLD)Outperform$22.00 -> $29.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/15/2017Leerink SwannReiteratesWAVE Life Sciences (WVE)Outperform$42.00 -> $53.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/15/2017Leerink SwannUpgradesTesaro (TSRO)Market Perform -> OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
11/15/2017Leerink SwannReiteratesClovis Oncology (CLVS)Outperform$107.00 -> $90.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/14/2017Leerink SwannUpgradesMirati Therapeutics (MRTX)Market Perform -> Outperform $9.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/13/2017Leerink SwannReiteratesEXACT Sciences (EXAS)Outperform$63.00 -> $67.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2017Leerink SwannRaises TargetSAGE Therapeutics (SAGE)Outperform -> Positive$85.00 -> $123.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2017Leerink SwannReiteratesTenet Healthcare (THC)Outperform$30.00 -> $25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2017Leerink SwannReiteratesInogen (INGN)Outperform$115.00 -> $120.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannRaises TargetUniqure (QURE)$19.00 -> $26.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannLowers TargetVeracyte (VCYT)Outperform$12.00 -> $9.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannLowers TargetInvitae (NVTA)Outperform$14.00 -> $12.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannRaises TargetDiplomat Pharmacy (DPLO)Market Perform$16.00 -> $20.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannReiteratesArbutus Biopharma (ABUS)Market Perform$4.00 -> $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannReiteratesNevro (NVRO)Outperform$105.00 -> $110.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannReiteratesHenry Schein (HSIC)Market Perform$87.50 -> $77.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannReiteratesCVS Health (CVS)Hold -> Outperform$90.00 -> $85.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannReiteratesAnthem (ANTM)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017Leerink SwannReiteratesDermira (DERM)Outperform$47.00 -> $41.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017Leerink SwannRaises TargetAxoGen (AXGN)Outperform$23.00 -> $26.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017Leerink SwannReiteratesOwens & Minor (OMI)Market Perform$34.00 -> $23.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017Leerink SwannReiteratesNeurocrine Biosciences (NBIX)Outperform$72.00 -> $83.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017Leerink SwannReiteratesJuno Therapeutics (JUNO)Outperform -> In-Line$34.00 -> $56.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017Leerink SwannReiteratesEpizyme (EPZM)Outperform$28.00 -> $22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/1/2017Leerink SwannReiteratesbluebird bio (BLUE)Outperform$145.00 -> $162.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/1/2017Leerink SwannDowngradesWalgreens Boots Alliance (WBA)Outperform -> Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
10/31/2017Leerink SwannRaises TargetIntellia Therapeutics (NTLA)Outperform$29.00 -> $37.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2017Leerink SwannReiteratesThermo Fisher Scientific (TMO)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/31/2017Leerink SwannReiteratesLifePoint Health (LPNT)Outperform$74.00 -> $58.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/31/2017Leerink SwannReiteratesEXACT Sciences (EXAS)Outperform$50.00 -> $63.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2017Leerink SwannReiteratesAmazon.com (AMZN)Outperform -> BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2017Leerink SwannLowers TargetMerck & Co. (MRK)Market Perform$70.00 -> $69.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/30/2017Leerink SwannLowers TargetAbbVie (ABBV)Outperform$108.00 -> $107.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2017Leerink SwannReiteratesAlign Technology (ALGN)Outperform $250.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/27/2017Leerink SwannRaises TargetPuma Biotechnology (PBYI)Positive -> Outperform $140.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannRaises TargetNovartis (NVS)Market Perform$89.00 -> $91.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannRaises TargetMerck & Co. (MRK)Market Perform$69.00 -> $70.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannRaises TargetEli Lilly and (LLY)Market Perform$92.00 -> $93.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannRaises TargetBristol-Myers Squibb (BMY)Outperform$61.00 -> $72.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannRaises TargetAstraZeneca (AZN)Market Perform$31.00 -> $34.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannRaises TargetIsotechnika Pharma (AUPH)Outperform$10.00 -> $14.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannLowers Targetathenahealth (ATHN)Market Perform$155.00 -> $125.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannInitiatesNightstar Therapeutics (NITE)Outperform -> Outperform $25.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/23/2017Leerink SwannSet Price TargetDBV Technologies (DBVT)Outperform$60.00 -> $49.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/20/2017Leerink SwannReiteratesCelgene (CELG)Buy $156.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/20/2017Leerink SwannRaises TargetUniqure (QURE)Outperform -> Outperform$17.00 -> $19.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/19/2017Leerink SwannRaises TargetGilead Sciences (GILD)Market Perform$84.00 -> $85.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/19/2017Leerink SwannReiteratesBioMarin Pharmaceutical (BMRN)Outperform$136.00 -> $142.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/19/2017Leerink SwannSet Price Targetathenahealth (ATHN)Hold $155.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/18/2017Leerink SwannReiteratesUnitedHealth Group (UNH)Buy$225.00 -> $240.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/18/2017Leerink SwannReiteratesJohnson & Johnson (JNJ)Outperform -> Outperform$150.00 -> $165.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/17/2017Leerink SwannReiteratesArdelyx (ARDX)Outperform $13.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/16/2017Leerink SwannInitiatesZai Lab (ZLAB)Outperform -> Outperform $42.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/12/2017Leerink SwannReiteratesNuVasive (NUVA)Outperform$74.00 -> $69.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/12/2017Leerink SwannReiteratesInsulet (PODD)Outperform$65.00 -> $74.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/12/2017Leerink SwannReiteratesAbiomed (ABMD)Outperform$180.00 -> $200.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/10/2017Leerink SwannReiteratesNeurocrine Biosciences (NBIX)Outperform$67.00 -> $72.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/9/2017Leerink SwannReiteratesAcadia Pharmaceuticals (ACAD)Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
10/9/2017Leerink SwannReiteratesMedtronic (MDT)Market Perform$88.00 -> $85.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/9/2017Leerink SwannRaises TargetThermo Fisher Scientific (TMO)Outperform$190.00 -> $207.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/9/2017Leerink SwannReiteratesAchaogen (AKAO)Outperform -> Outperform$28.00 -> $22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/6/2017Leerink SwannReiteratesbluebird bio (BLUE)Outperform$120.00 -> $145.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/5/2017Leerink SwannRaises TargetGilead Sciences (GILD)Market Perform$87.00 -> $89.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/4/2017Leerink SwannReiteratesAmicus Therapeutics (FOLD)Buy$17.00 -> $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/2/2017Leerink SwannReiteratesZogenix (ZGNX)Outperform -> Outperform$20.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2017Leerink SwannReiteratesMyriad Genetics (MYGN)Mkt Perform -> Market Perform $31.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/2/2017Leerink SwannReiteratesGW Pharmaceuticals (GWPH)Outperform$160.00 -> $153.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/2/2017Leerink SwannUpgradesAbbVie (ABBV)Market Perform -> Outperform$89.00 -> $106.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/30/2017Leerink SwannReiteratesbluebird bio (BLUE)Outperform $120.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/30/2017Leerink SwannReiteratesAxoGen (AXGN)Outperform$22.00 -> $23.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/30/2017Leerink SwannReiteratesSarepta Therapeutics (SRPT)Outperform $66.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/29/2017Leerink SwannReiteratesDexcom (DXCM)Buy$85.00 -> $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/26/2017Leerink SwannReiteratesProQR Therapeutics (PRQR)Outperform$10.00 -> $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/26/2017Leerink SwannUpgradesDova Pharmaceuticals (DOVA)Market Perform -> Outperform $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/25/2017Leerink SwannReiteratesAlexion Pharmaceuticals (ALXN)Buy $182.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/23/2017Leerink SwannLowers TargetIntercept Pharmaceuticals (ICPT)Market Perform$120.00 -> $66.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/22/2017Leerink SwannRaises TargetUniversal Health Services (UHS)Outperform$130.00 -> $132.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/22/2017Leerink SwannDowngradesExelixis (EXEL)Outperform -> Market Perform$34.00 -> $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/21/2017Leerink SwannReiteratesEXACT Sciences (EXAS)Outperform -> Outperform$45.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/20/2017Leerink SwannReiteratesGilead Sciences (GILD)Market Perform$82.00 -> $87.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/20/2017Leerink SwannReiteratesNuVasive (NUVA)Outperform -> Buy$87.00 -> $74.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/18/2017Leerink SwannReiteratesClovis Oncology (CLVS)Buy $107.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/19/2017Leerink SwannInitiatesSynlogic (SYBX)Outperform -> Outperform $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/18/2017Leerink SwannReiteratesNabriva Therapeutics (NBRV)Outperform$20.00 -> $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/16/2017Leerink SwannReiteratesAmicus Therapeutics (FOLD)Outperform$18.00 -> $17.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/15/2017Leerink SwannRaises TargetMirati Therapeutics (MRTX)Mkt Perform -> Market Perform$7.00 -> $9.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/13/2017Leerink SwannReiteratesCentene (CNC)Market Perform -> Market Perform$78.00 -> $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/13/2017Leerink SwannInitiatesReata Pharmaceuticals (RETA)Outperform -> Outperform $43.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/13/2017Leerink SwannReiteratesAlexion Pharmaceuticals (ALXN)Outperform -> Outperform$170.00 -> $182.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/12/2017Leerink SwannReiteratesAbbVie (ABBV)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
9/12/2017Leerink SwannReiteratesVocera Communications (VCRA)Outperform$31.00 -> $34.00LowView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Thursday at 07:34 PM ET.

MarketBeat Community Rating for Leerink Swann

Community Ranking:  0.0 out of 5 (star star half star)
Outperform Votes:  0 (Vote Outperform)
Underperform Votes:  1,866 (Vote Underperform)
Total Votes:  1,866
MarketBeat's community ratings are surveys of what our community members think about Leerink Swann and other research firms. Vote "Outperform" if you believe Leerink Swann's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Leerink Swann's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.